Megace

Medicinal product

(Invented) name

Megace

Active substance (s)

Megestrolis

Strength

40 mg/ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AB01, Megestrol

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2013-04-09

Date of renewal

Documents

0159-001_Megace_2021-02-24.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml suspensijos yra	1 ml
Megestrolis	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
55848	69901	1069901	buteliukas	240 ml ir matavimo taurelė (35 ml) N1		Receptinis	LT/L/13/0159/001	Netiekiama	2024-10-23	2025-04-23	No	-	-	Download

Stadijos

Data	Stadija
2013-04-09	Registruotas